jueves, 6 de agosto de 2020

No benefit of plasma therapy in reducing COVID-19 mortality risk, says AIIMS trial interim analysis | India News,The Indian Express

No benefit of plasma therapy in reducing COVID-19 mortality risk, says AIIMS trial interim analysis | India News,The Indian Express

Plasma donation, coronavirus cases, Mumbai news, Maharashtra news, Indian express news

No benefit of plasma therapy in reducing COVID-19 mortality risk, says AIIMS trial interim analysis

The therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus infected patient to help kickstart the immune system to fight back the infection.

No hay comentarios: